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Streptococcus uberis strains isolated 
from the bovine mammary gland evade 
immune recognition by mammary epithelial 
cells, but not of macrophages
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Abstract 
Streptococcus uberis is frequently isolated from the mammary gland of dairy cattle. Infection with some strains can 
induce mild subclinical inflammation whilst others induce severe inflammation and clinical mastitis. We compared 
here the inflammatory response of primary cultures of bovine mammary epithelial cells (pbMEC) towards S. uberis 
strains collected from clinical or subclinical cases (seven strains each) of mastitis with the strong response elicited by 
Escherichia coli. Neither heat inactivated nor live S. uberis induced the expression of 10 key immune genes (includ‑
ing TNF, IL1B, IL6). The widely used virulent strain 0140J and the avirulent strain, EF20 elicited similar responses; as did 
mutants defective in capsule (hasA) or biofilm formation (sub0538 and sub0539). Streptococcus uberis failed to activate 
NF‑κB in pbMEC or TLR2 in HEK293 cells, indicating that S. uberis particles did not induce any TLR‑signaling in MEC. 
However, preparations of lipoteichoic acid (LTA) from two strains strongly induced immune gene expression and 
activated NF‑κB in pbMEC, without the involvement of TLR2. The immune‑stimulatory LTA must be arranged in the 
intact S. uberis such that it is unrecognizable by the relevant pathogen receptors of the MEC. The absence of immune 
recognition is specific for MEC, since the same S. uberis preparations strongly induced immune gene expression and 
NF‑κB activity in the murine macrophage model cell RAW264.7. Hence, the sluggish immune response of MEC and 
not of professional immune cells to this pathogen may aid establishment of the often encountered belated and sub‑
clinical phenotype of S. uberis mastitis.
© 2016 Günther et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
The Gram-positive bacterium Streptococcus uberis is 
among the four most prevalent species of mastitis caus-
ing pathogens [1, 2]. Infection with this bacterium can 
occur with very few if any clinical signs, but can also 
result in severe inflammation of the udder culminating in 
clinical mastitis [3]. It is not entirely clear if the heteroge-
neous physiology of S. uberis mastitis is caused by genetic 
diversity of the different strains infecting the udders. 
There is an extraordinary diversity of S. uberis strains [4, 
5] and clear examples of strains that reproducibly induce 
clinical or subclinical infections have been reported 
[5–7]. There are reports that occasionally a predomi-
nant strain infected several cows within a herd [8] but it 
was also found that genetically distinct S. uberis strains 
infected different individuals within a herd and distinct 
strains caused re-infection after a previous successful 
cure of a first S. uberis infection [9, 10].
Multilocus sequence typing studies suggested that 
mastitis causing S. uberis strains (clinical and subclinical) 
may be genetically different from avirulent strains [11]. 
However, no clear gene-loss or -gain correlation with the 
virulent or avirulent phenotype of the strains emerged in 
a very recent comparison of the whole genome sequences 
from thirteen different S. uberis strains [5]. This sug-
gests that the particular outcome of an udder infection 
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is largely determined by the host-pathogen interaction 
rather than by the particular genotype of the pathogen.
Streptococcus uberis vs. cow interactions have been 
studied in several udder infection experiments. S. 
uberis generally elicited a belated onset of inflam-
mation, compared to infections with E. coli or other 
Gram-negative pathogens [12, 13]. Comparing global 
transcriptome profiling from S. uberis vs. E. coli infec-
tion trials reveals a remarkable failure of S. uberis to 
induce expression of pro-inflammatory cytokine and 
chemokine-encoding genes in the udder [14–19]. It 
rather appeared that S. uberis infection up-regulated 
IL10 and IL6 governed pathways, which are both 
known to eventually counteract strong inflammation 
[15]. Moreover, these studies recapitulated the physi-
ological variability in the outcome of S. uberis udder 
infections. While the widely used strain 0140J—known 
as the almost prototypical strain for eliciting clinical 
mastitis [6, 20]—caused clinical mastitis in one of these 
infections trials [15], it elicited subclinical mastitis in 
the second trial [16].
Mammary epithelial cells (MEC) of the lactating udder 
parenchyma are the dominant cell type coming into con-
tact with invading pathogens early on after infection. 
Quantitative morphometry revealed that MEC comprise 
more than 70% of the udder cells [21, 22]. MEC are the 
dominant sentinels of the lactating parenchyma and 
competent to mount the first cytokine alert [17, 23–25]. 
They express not only the relevant Toll-like-receptors 
(TLRs) for perceiving pathogens but also β-defensin-
encoding genes to counteract alveolar colonization of the 
pathogens [26–28]. It was reported that challenging these 
cells with only some strains of S. uberis, but not with oth-
ers, would activate cytokine genes expression in these 
cells [14, 29].
Epithelial cells are known to perceive pathogens 
through pathogen recognition receptors (PRR) includ-
ing the family of TLRs [30]. Thirteen mammalian TLRs 
are known. Binding of their ligands (collectively known 
as Pathogen Associated Molecular Patterns; PAMPs) 
activates their downstream signaling. This ultimately 
leads to the activation of the NF-κB factor complex, 
mediated through a multifactorial cascade [31]. These 
transcription factors regulate the expression of a wealth 
of immune genes [32–34]. TLR2 is known to be essen-
tial for mounting an efficient immune defence against 
Gram-positive bacteria [35–37]. Lipoproteins from these 
pathogens belong to its natural ligands [38, 39]. However, 
it was reported that Gram-positive Group B streptococci 
(e.g. S. agalactiae) did not activate TLR2 [40]. Moreover, 
mitomycin-C inactivated S. uberis preparations did not 
activate the bovine TLR2 receptor in HEK293 cells [41]. 
Failure to activating a TLR mediated immune response 
would readily explain the slow and weak immune 
response caused by a S. uberis challenge.
We wanted to know if the divergent physiology of S. 
uberis mastitis might in tendency be related to S. uberis 
strain specific differences in the interaction with the 
MEC. Therefore, we wanted to establish a broader survey 
of the capacity of diverse S. uberis isolates from clinical 
and subclinical cases of mastitis to stimulate immune 
functions of MEC. We included previously used model 
strains either known to causing mastitis or as being 
avirulent for direct comparison of the results with cur-
rent knowledge. We were also curious about the possi-
ble divergent immune stimulatory properties of cell wall 
components isolated from different strains to see if they 
would possibly cause a strain dependent difference in 
eliciting an immune response.
Our parameters for the induction of immune functions 
consisted of the pathogen challenge -related modulation 
of the expression of a panel of cytokine- and chemokine-
encoding genes (such as TNF, IL1A, IL6, CXCL8) but also 
those encoding effectors of immune defence (β-defensin 
LAP, NOS2A) or membrane protecting factors (SAA). 
Their relevance as markers for induced immune func-
tions in MEC has previously been established [17]. 
Additionally, we monitored the activation of the NF-κB 
transcription factor complex. We show that—under our 
experimental conditions—all the S. uberis strains failed 
to significantly induce immune functions in the MEC, 
but not in macrophage model cells.
Materials and methods
Mastitis pathogen strains
Streptococcus uberis strains used in this study are 233 
(obtained from the AgResearch New Zealand [14]), 0140J 
(ATCC® Number BAA-854, isolated from clinical masti-
tis, 1972 in the UK), EF20 (avirulent strain isolated from 
clinical mastitis, 1970 in the UK [6], ΔhasA (noncapsu-
lar hyaluronate synthase A mutant derivative of strain 
0140J; [42]); 0140J::ISS1 P’ (mutant of 0140J, inactivation 
of the promoter addressing the glycosyltransferase genes 
sub0538 and sub0539 which significantly reduced the 
ability to form biofilm [43]); T1–18 and T2–58 (isolated 
from cases of mastitis in the UK, provided by Dr Michael 
Fontaine, Moredun Research Institute, UK). The S. uberis 
strains C6344, C5072, S6261, C9359, Ab71 (all isolated 
2002 in the UK), 4428 (1999, UK), 5291 (2000, UK) 
were isolated from clinical cases while C8329, C5388, 
C7131, S7010 (all isolated 2002 in the UK), B190, B362 
(2000, UK), 6736 (1999, UK) were isolated from subclini-
cal cases of mastitis. S. agalactiae 0250 and S. dysgalac-
tiae 2023 were isolated from cases of bovine mastitis 
in the UK and are included in the National Institute for 
Research in Dairying culture collection (currently hosted 
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by Prof. James Leigh at the University of Nottingham). 
E. coli strain 1303 is a well characterized mastitis model 
strain isolated from udder secretions of a cow with clini-
cal mastitis [19].
Bacterial growth and preparation of pathogen particles
Details regarding culturing E. coli1303 and its use to chal-
lenge the pbMEC were exactly as described [17]. S. uberis, 
S. agalactiae and S. dysgalactiae were grown in Todd 
Hewitt Broth (THB, Carl Roth GmbH) at 37  °C without 
agitation to the logarithmic phase of culture growth (0.5, 
OD600 nm). Plating of dilution series was used to calibrate 
cell counts from the OD readings. Efficacy of killing the 
bacteria through heat treatment (60 min, 80 °C) was veri-
fied by control plating. Heat treated cells were collected 
by centrifugation, washed twice with RPMI 1640 medium 
(Biochrom), and re-suspended therein. Aliquots were 
stored frozen at −20 °C. We applied in challenge experi-
ments similar protein concentrations of the heat killed 
bacteria from the different strains in order to standardize 
the conditions. Protein contents of the bacterial prepara-
tions had been determined with the Lowry procedure 
[44]. Based on three independent growth experiments, we 
found from exponentially multiplying cultures (OD600nm, 
0.5) as protein content ~16.8 ± 4.1 and ~5.8 ± 0.8 µg/107 
bacteria for of E. coli1303 and S. uberis strain 0140J, respec-
tively. The other S. uberis strains had protein contents 
similar that determined for 0140J.
LTA preparation
LTAs were isolated as described by Morath et  al. [45] 
with few modifications as detailed [46]. Treatment of lyo-
philized native LTA with 1% H2O2 in phosphate-buffered 
saline (PBS) inactivated contaminating lipoproteins [47]. 
Our NRM spectroscopy analysis proved that the LTA 
core structure was not altered by that treatment. LTA 
preparations were endotoxin free as judged by their fail-
ure to activate the bovine TLR4 in the HEK293 cells. The 
latter assays were conducted as previously described [27].
Cell culture procedure
Tissue cultures of pbMEC were established as described 
[27]. Their cultivation and pathogen stimulation on col-
lagen IV coated tissue culture plates in RPMI 1640 
(Biochrom) supplemented with insulin, prolactin, dexa-
methasone and 10% FCS (PAN-Biotech) was as detailed 
by Günther et al. [17]. Briefly, frozen aliquots of pbMEC 
were seeded at high cell density into 9  cm dishes, puri-
fied through selective trypsinization and reseeded for 
experiments into six well plates, again at high cell density. 
After settling overnight duplicate wells were challenged 
at various times (t0, t21, t23  h) through the addition of 
30 µg/mL of protein from heat killed bacteria. Duplicate 
unstimulated control cultures were kept in parallel. All 
cultures were collected at t24 h for RNA extraction.
RAW264.7 cells (from ATCC) were cultivated in 
DMEM (Biochrom) supplemented with 2  mM  l-glu-
tamine and 10% FCS. Stimulation experiments were simi-
larly performed using 80% confluent cell cultures.
All tissues and cells were retrieved from healthy first 
lactating Holstein–Friesian heifers having been slaugh-
tered in our local abattoir, complying with all pertinent 
ethical and legal requirements. The abattoir is a EU 
licensed (ES1635) core facility of the research affiliation 
and serves to routinely supply samples to different labo-
ratories. Special ethical approval was unnecessary since 
the cows had been culled in the normal culling regime 
without conducting any animal experimentation.
RNA extraction and mRNA quantification
RNA was extracted with TRIZOL-reagent (Invitrogen). 
Preparation of the cDNA (Superscript II, Invitrogen) 
and real time quantification of the mRNA concentra-
tions with the Fast-Start Sybr Green I kit and the Light-
Cycler II instrument (Roche) were done essentially as 
described [26], however using per assay a cDNA input 
derived from 75  ng of total RNA. Titration of relative 
copy numbers against external standards and normali-
zation against the not regulated reference gene chloride 
intracellular channel 1 (CLIC1) were done as detailed in 
[48]. Sequences of oligo nucleotide primers are listed in 
Additional file 1.
Determination of NF‑κB activation
NF-κB activity was assessed with a reporter gene express-
ing the Renilla-luciferase under the control of the NF-κB 
activated ELAM promoter (Invivogen; [27]). This ref-
erence describes also the vector expressing the bovine 
TLR2 receptor. These constructs were transfected into 
pbMEC and HEK293 cells with Lipofectamine 2000 (Inv-
itrogen) essentially as previously described in detail [49].
Macrophages are notorious for being difficult to trans-
fect due to the natural response of phagocytes against 
foreign materials. Therefore RAW264.7 cells were trans-
fected using the Neon® Transfection System (Life Tech-
nologies) following the manufacturer’s instructions for 
this specific cell type. Briefly 5  µg of the ELAM NF-κB 
reporter plasmid were used to transfect 106 cells with one 
pulse of 1580  V for 20  ms. Subsequently the cells were 
seeded into wells of 24-well plates. The cells were allowed 
to recover overnight prior to stimulation. After challeng-
ing with the respective stimulus for the time as indicated, 
the cells were lysed and luciferase activity was assayed 
using the dual luciferase assay reporter system (Promega) 
as detailed [27]. The enzyme activity was calibrated 
against the protein content of the lysate.
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Stimulation with live pathogens
Pathogens were grown to the logarithmic phase of cul-
ture growth (0.5, OD600nm) in the respective growth 
medium. Subsequently, the bacteria were washed twice 
with RPMI 1640 medium and resuspended therein. They 
were co-cultured with pbMEC in RPMI 1640 medium 
(without antibiotics) for 1  h with 107 CFU/mL of the 
respective pathogen. Subsequently pathogens were killed 
by adding 100  µg/mL gentamicin. For mRNA quantifi-
cation the pbMEC were either instantly harvested (1  h 
time point) or cultured for another 2 or 23 h in pbMEC 
growth medium (3 and 24 h time point, respectively). For 
luciferase measurement of NF-κB activation lysates were 
prepared 23 h after bacterial killing with gentamicin.
Statistical analysis
The data were analysed with GraphPad Prism Version 5 
(GraphPad Software, Inc., La Jolla, CA, USA). Differences 
were evaluated through an analysis of variance (ANOVA) 
including Bonferroni’s correction for pairwise multiple 
comparisons.
Results
Streptococcus uberis strains failed to activate immune gene 
expression in pbMEC
Dose finding studies had confirmed in pilot experiments 
that preparations of the heat-killed particles from the 
non-encapsulated strain 233 did not significantly induce 
cytokine gene expression in pbMEC [14], even if applied 
at high concentrations (up to 108 particles/mL; data 
not shown). The pathogen concentration in the milk of 
S. uberis infected udders is known to reach  ~107 CFU/
mL [5, 13]. We then surveyed the immune stimulatory 
properties of a broader collection of strains isolated from 
either clinical or subclinical cases of mastitis to eventually 
find indications for strain specific differences. pbMEC 
cultures were stimulated for up to 24 h with 30 µg/mL of 
protein from heat-killed preparations of seven different 
strains each isolated from clinical or subclinical cases of 
mastitis. Thus, approximately 100 bacterial particles were 
applied per MEC host cell (MOI ~100). A similarly prep-
aration of E. coli1303 was included as a positive control. 
Contrary to E. coli, all S. uberis strains failed to signifi-
cantly activate gene expression of seven different immune 
genes (TNF, CXCL8 (Figure 1), IL1A, IL6, CCL5, SAA3, 
β-defensin LAP; data not shown). No difference was 
observed between isolates obtained from clinical or sub-
clinical infection. However, expression of CYP1A1 was 
strongly induced to a similar extent by all bacterial prepa-
rations (Figure 1), validating that the cells had perceived 
presence of disturbing compounds in their environment. 
Expression of this general detoxification enzyme [50] is 
induced by a wide variety of xenobiotic stress and largely 
regulated by the aryl hydrocarbon receptor (AhR) and its 
nuclear translocator (ARNT; see [51, 52] for reviews).
 We repeated the survey using another two different 
mastitis isolates, strain 233 and the widely used strain 
0140J. Again, no significant induction of the candi-
date immune genes was recorded (Additional file  2) 
and these data validate that the absence of immune 
stimulatory properties of the model strains 0140J and 
233 on MEC are typical for mastitis causing S. uberis 
pathogens.
As the presence of the capsule is positively correlated 
with isolates from clinical disease [53], we next exam-
ined if the capsule might be responsible for the poor 
immune stimulatory properties of S. uberis on MEC. 
The ΔhasA mutant of strain 0140J cannot form cap-
sule [42]. We found that it was as ineffective in activat-
ing an immune response in pbMEC as the wild type 
strain (Figure  2A). Similarly ineffective was a mutant 
of S. uberis strain 0140J with a fivefold reduced capac-
ity to express a key gene involved in glycolipid forma-
tion and proven reduced capacity for biofilm formation 
(Figure 2B).
We have recently observed that addition of 10% 
FCS greatly quenched the reactivity of pbMEC against 
Staphylococcus aureus, another representative of a 
Gram-positive pathogen [48]. Hence, we examined the 
effect of FCS supplementation on the pbMEC response 
against S. uberis. Therefore the pbMEC were grown in 
normal growth medium. They were then washed twice 
with PBS and growth medium devoid of FCS was added. 
The cells were challenged in this medium for three h 
with S. uberis233, E.coli1303 and similar preparations of S. 
aureus1027. E. coli and S. aureus quite strongly induced 
the expression of most of our candidate immune genes. 
However, the response against S. uberis was to that 
recorded in normal growth medium (Additional file 3).
Streptococcus uberis did not quench the reaction of pbMEC 
against E. coli
It has been reported that components of the S. uberis 
capsule may impair neutrophil functions [53]. We there-
fore examined, if pre-incubating pbMEC with S. uberis 
might impair the immune reactivity of the host cells. Cul-
tures were pre-incubated for 1 h with 30 µg/mL of heat-
killed particles from either of two S. uberis strains and 
subsequently challenged with a mild dose (3  µg/mL) of 
heat-killed E. coli particles. Scoring the mRNA concen-
trations of our panel of immune genes revealed no indi-
cation that pre-incubation reduced the immune response 
to E. coli; the expression of all these genes subsequent to 
the E. coli challenge was almost identical in S. uberis pre-
incubated cultures and their respective controls (Addi-
tional file 4).
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Live S. uberis elicited only a slightly enforced immune 
reaction
Any method to inactivate pathogens alters the surface 
composition of the particles. Hence, we analyzed if co-
culturing the pbMEC with live pathogens would hasten 
and inforce the immune reaction of the pbMEC. We 
therefore co-cultured these cells for 1  h with 107 CFU/
mL of S. uberis strain 0140J. Then the bacteria were killed 
through the addition of 100  µg/mL of gentamicin and 
the cultures were subsequently sampled at various times. 
Induction of immune gene expression was again found 
to be weaker by an order of magnitude than elicited by 
a similar challenge with E. coli (Table 1). However, live S. 
uberis pathogens induced the expression several genes 
(TNF, IL6, CXCL8) to a slightly larger extent than the 
heat-killed pathogens.
Streptococcus uberis failed to elicit TLR2 signaling 
and NF‑κB activation in MEC
We examined if a lack of TLR activation might be the 
underlying cause for the absence of any immune gene 
activation in MEC. On the one hand we inquired about 
the S. uberis mediated activation of the TLR2 receptor, 
since there is compelling evidence that this particular 
TLR is crucially involved in counteracting infection by 
Gram-positive pathogens [35, 38] and a previous report 
had suggested that TLR2 might not be activated by S. 
uberis [41]. HEK293 cells were co-transfected with our 
construct expressing the bovine TLR2 factor and the 
NF-κB driven luciferase reporter construct. Ligand medi-
ated NF-κB activation would indicate TLR2 activation. 
None of the two S. uberis strains activated NF-κB in the 
HEK293 cells, even at very high concentrations of parti-
cles added (75 µg/mL equaling a MOI of approximately 
300; Figure  3A). However, heat-killed particles of other 
streptococcal species (S. dysgalactiae and S. agalactiae) 
induced TLR2 to a similar extent as challenging with E. 
coli, which had been included as a positive control.
Pathogen-induced signaling from all TLR receptors is 
known to ultimately culminate in the functional activa-
tion of the NF-κB factor complex. Hence, we analyzed 
if S. uberis would at all activate NF-κB in pbMEC. In 
one set of experiments, we transfected the pbMEC cells 
with the NF-κB reporter construct and subsequently 
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Figure 1 Streptococcus uberis strains from clinical or subclinical cases of mastitis did not activate immune functions of pbMEC. Induc‑
tion of gene expression (ordinate) of TNF, CXCL8 and CYP1A1 after challenging for 0, 1, 3 and 24 h (abscissa) with 30 µg/mL of 14 different heat‑killed 
S. uberis strains isolated from clinical (A) or subclinical (B) cases of mastitis compared against E. coli1303. Values are RT‑qPCR measurements of the 
respective mRNA species, normalized against CLIC1 and expressed as multiple of the value measured from the unstimulated control. Values are 
from a single experiment, assayed in duplicate. Only E. coli1303 elicited a significant induction (compared to control, p < 0.05) of TNF and CXCL8. All 
preparations strongly induced the expression of CYP1A1.
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Figure 2 Neither S. uberis mutants with defects in the formation of a hyaluronic acid capsule or in glycolipid biosynthesis nor an avir-
ulent strain activated immune functions of pbMEC. A Induction of gene expression (ordinate) of TNF, CXCL8 and NOS2A after challenging with 
30 µg/mL of heat‑killed 0140J hasA mutant (ΔhasA) compared against two different preparations of wild‑type 0140J (0140J wta/b) and E. coli1303 for 
the time as indicated (abscissa). All preparations strongly induced the expression of CYP1A1. Values are from a single experiment representative for 
three, each assayed in duplicate. B Same experimental setting as before, but the challenge time was 3 h only. EF20, avirulent strain; 0140J::ISS1 P’, 
mutant defective for glycolipid biosynthesis. The experiment was assayed in triplicate. Asterisks indicate significance of the different mean values 
from the control (p < 0.05).
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challenged the cells with heat-killed particles from three 
different stains. We found in all cases a 30% increase of 
the active NF-κB factors. However, the stimulations were 
statistically insignificant (Figure 3B, left hand panel). We 
repeated the experiment with live pathogens. The trans-
fected cells were co-cultured with live pathogens (MOI, 
30) for 1 h. Subsequently, the pathogens were killed (but 
kept in the culture fluid) by the addition of 100  µg/mL 
of gentamicin and the NF-κB activity was assayed 24  h 
later. The result was similar. Challenge with live S. uberis 
pathogens (strains 0140J and 233) did not significantly 
increase the level of active NF-κB (Figure 3B, right hand 
panel).
These results together show that S. uberis, either as live 
pathogen or as heat-killed particle avoids almost com-
pletely triggering any TLR-signaling. The particles are 
unrecognizable by TLR2 and this deficit is not efficiently 
compensated for by any other pathogen receptor.
LTAs from S. uberis activated immune gene expression 
and NF‑κB in pbMEC, but not through TLR2 activation
Given the almost absent stimulatory capacity of the 
S. uberis particles, we wondered if LTAs as major cell 
envelope components would stimulate immune gene 
expression in pbMEC. LTAs were isolated from two 
different strains. Both preparations strongly activated 
expression of our candidate immune genes. The examples 
shown in Figure  4A and Table  2 also demonstrate that 
there was no difference between the LTAs isolated from 
the strains 233 and T1–18. 
Table 1 Extent and kinetics of modulated mRNA concen-
trations after stimulating pbMEC with live E. coli1303 or S. 
uberis strain 0140J.
pbMEC were co-cultured for 1 h with 107  CFU of the respective pathogen. 
Subsequently, pathogens were killed by adding 100 µg/mL gentamicin. mRNA 
was harvested either instantly (1 h time point) or after culturing for another 
2 or 23 h (3 and 24 h time point, respectively). Values are means (±SEM) of 
fold change relative to the unstimulated control from two biological replica 
experiments, each assayed in duplicate. Numbers given in bold font indicate 
significant regulation
Gene Pathogen Time
1 h 3 h 24 h
TNF E. coli 1303 5 ± 0 88 ± 1 34 ± 10
S. uberis 0140J 2 ± 1 11 ± 3 2 ± 1
IL6 E. coli 1303 3 ± 1 34 ± 0 7 ± 2
S. uberis 0140J 1 ± 0 3 ± 0 1 ± 0
CXCL8 E. coli 1303 6 ± 0 213 ± 9 36 ± 5
S. uberis 0140J 1 ± 0 17 ± 10 5 ± 2
CCL5 E. coli 1303 1 ± 0 14 ± 6 124 ± 85
S. uberis 0140J 1 ± 0 1 ± 0 1 ± 1
NOS2A E. coli 1303 4 ± 1 137 ± 11 17 ± 6
S. uberis 0140J 1 ± 1 7 ± 1 1 ± 0
LAP E. coli 1303 1 ± 0 5 ± 0 54 ± 8
S. uberis 0140J 1 ± 0 1 ± 0 2 ± 0
SAA3 E. coli 1303 1 ± 0 13 ± 1 72 ± 35
S. uberis 0140J 1 ± 0 2 ± 0 2 ± 1
CYP1A1 E. coli 1303 77 ± 12 445 ± 61 3 ± 1
S. uberis 0140J 79 ± 39 590 ± 122 5 ± 1 0
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Figure 3 Capacity of streptococcal pathogens to activate TLR2 
and NF-κB. A S. uberis, but not other streptococcal species failed to 
activate NF‑κB in the HEK293 reconstitution system of TLR2‑signaling. 
HEK293 cells were transfected with constructs expressing the 
bovine TLR2 receptor (200 ng) and the Renilla luciferase expressing 
reporter gene being driven by NF‑κB through its ELAM promoter. 
Subsequently, the cells were challenged for 24 h with different dose 
(abscissa) of heat‑killed streptococcal strains or E. coli1303. The lucif‑
erase activity was measured from cell lysates and normalized against 
their protein concentration. Values are expressed as fold increase 
above the level of the unstimulated control (ordinate). Each transfec‑
tion was run in duplicate and assayed from triplicate challenges. 
(*p < 0.05; ***p < 0.001, regarding the difference to the unstimulated 
control). B S. uberis bacteria, dead or alive failed to activate NF‑κB 
in pbMEC. pbMEC were transfected with the ELAM driven reporter 
gene construct (100 ng) and either stimulated with 30 µg/mL of 
the heat‑killed bacteria (as indicated; left hand panel) or incubated 
for 1 h with 107 live bacteria/mL. Bacteria were subsequently killed 
with 100 µg/mL gentamicin and the cultures incubated for another 
23 h. Thereafter, the Renilla activity was measured from cell lysates 
and expressed as multiple of the respective unstimulated control 
(ordinate; tabulated values below the graph, mean ± SEM, n = 2 
independent experiments, each assayed in triplicate). Only the NF‑κB 
inductions in response to the E. coli challenges were statistically 
significant (p < 0.001).
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Strong induction of immune gene expression in 
pbMEC was accompanied by significant activation of 
NF-κB factors (Figure 4B, left hand panel). Inactivation of 
potentially co-isolated lipoprotein components through 
peroxide treatment significantly reduced the NF-κB stim-
ulation by these LTA preparations. The slight residual 
NF-κB activation was statistically insignificant. We also 
investigated if other components of the S. uberis strain 
233 cell envelope (lipoproteins, lipids, glycolipids) might 
activate NF-κB factors in pbMEC. None of those com-
ponents significantly activated NF-κB in pbMEC (Addi-
tional file 5).
The NF-κB stimulatory activity of the LTA preparations 
was not mediated through TLR2. This became clear by 
analyzing the NF-κB stimulatory activity of these prepa-
rations in the HEK293 reconstitution system of TLR2 
activation (Figure  4B, right hand panel). The HEK293 
cells were co-transfected with the NF-κB driven lucif-
erase reporter gene and a vector expressing the bovine 
TLR2 receptor. Stimulations with different dose of the 
native LTA preparations only slightly elevated the level 
of active NF-κB factors. Peroxide treatment of the same 
LTA preparations abolished completely their capacity 
to activate NF-κB. E. coli, on the other hand activated 
NF-κB in these experiments very strongly, by more than 
11 fold.
These data together show that the cell envelope com-
ponent LTA isolated from S. uberis is in principal 
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Figure 4 LTA significantly activated immune gene expression and NF-κB in pbMEC, but not through TLR2 activation. A pbMEC were 
stimulated with 10 µg/mL of the respective LTA preparation for the time, as indicated (abscissa). TNF and CXCL8 mRNA concentrations were meas‑
ured from duplicate assays, normalized against the CLIC1 reference and expressed as multiples of the concentration from unstimulated controls 
(*p < 0.05). B The same LTA preparations or their peroxide treated derivatives were used to stimulate pbMEC cultures having previously been 
transfected with the ELAM driven NF‑κB reporter gene (left hand panel, stimulated with 10 µg/mL LTA) or HEK293 cells, having been co‑transfected 
with that NF‑κB reporter and the construct expressing the bovine TLR2 receptor. The different dose of the challenge substance is indicated. $E. coli 
stimulation was with 30 µg/mL. These experiments are representative for three (left panel) or two (right panel) each assayed in triplicate.
Page 9 of 14Günther et al. Vet Res  (2016) 47:13 
recognizable by receptors of the pbMEC relevant for trig-
gering an immune alert.
Streptococcus uberis strongly activated immune gene 
expression and NF‑κB factors in murine RAW264.7 
macrophage model cells
The poor immune stimulatory capacity of S. uberis was 
peculiar for pbMEC. This was found by stimulating the 
murine macrophage model cell line RAW264.7 with the 
same S. uberis preparations as used in the pbMEC stimu-
lations. Challenging these cells with heat-killed particles 
from three different S. uberis strains resulted in a sig-
nificant and strong induction of all immune genes exam-
ined (Figure 5A). They induced expression of the CXCL2 
encoding gene to a similar extent as E. coli. The other 
three genes analyzed (TNF, IL6, CCL5) were also all sig-
nificantly induced by all three S. uberis strains, albeit to a 
lesser extent than by E. coli. These inductions of immune 
gene expression were paralleled by strong and significant 
activation of NF-κB factors in these cells, similarly as 
caused by challenging them with E. coli (Figure 5B).
Discussion
It is still unclear whether or not the physiological out-
come of an udder infection with S. uberis as either clinical 
or sub-clinical mastitis relates to the divergent genotypes 
of respective pathogen. The controversial literature in 
this regard was recently extensively reviewed by Zadoks 
et al. [2]. The overarching goal of our study was therefore 
to examine if the respective mastitis physiology might 
be caused by S. uberis strain specific differences in the 
interaction with the MEC. As a first step, we used here 
for most of the experiments preparations of heat killed 
S. uberis particles from diverse strains to ensure good 
technical reproducibility. It is known that PAMPs acti-
vate immune functions in MEC very quickly (<1 h; [48]). 
Our experimental setting thus mainly focused on even-
tual differences in the passive—PAMP-related—immune 
induction capacity of the various S. uberis strains and 
ignored the possibly very crucial effects of virulence fac-
tors secreted by the live pathogens. Their effect emerges 
at later times during host pathogen interaction, after 
their accumulation in high enough concentrations in the 
alveolar fluid to significantly modulate the MEC immune 
responsiveness.
We conducted the study on the background of our 
broad experiences regarding the pathogen-species spe-
cific immune response of the pbMEC model system 
towards challenges with E. coli and S. aureus mastitis 
pathogens under various experimental conditions [17, 48, 
49, 54].
It is a prevalent property of S. uberis to not trigger immune 
functions in MEC
Our key observation is that the MEC generally does not 
mount an adequate immune response against S. uberis. 
This general immune unresponsiveness of these cells 
occurred in our experiments, albeit that the cells had 
perceived indeed the xenobiotic stress caused by the 
presence of the bacteria in the environment as shown 
by the strong, uniform and dose dependent induction of 
CYP1A1 expression by heat-killed bacteria, irrespective of 
Table 2 Extent and kinetics of modulated mRNA concen-
trations after stimulating pbMEC with native LTA from S. 
uberis strain 233 and T1–18.
pbMEC were stimulated with 1 or 10 µg/mL LTA for the indicated time. Values 
are means (±SEM) of fold change relative to unstimulated control from two 
biological replica experiments, each assayed in duplicate; bold numbers 
represent significant regulation
Gene LTA from  
strain
Concentra‑
tion  
(µg/mL)
Time
1 h 3 h 24 h
TNF 233 1 4.6 ± 0.3 68 ± 1.8 3.2 ± 0.2
10 5.7 ± 0.0 110 ± 2.9 14.1 ± 0.2
T1–18 1 3.6 ± 0.3 44 ± 10.0 2.8 ± 0.1
10 6.1 ± 0.3 114 ± 2.2 13.4 ± 0.3
IL6 233 1 1.2 ± 0.0 10.2 ± 0.8 1.9 ± 0.1
10 1.3 ± 0.1 18.5 ± 0.2 4.3 ± 0.04
T1–18 1 1.2 ± 0.1 7.1 ± 1.7 1.7 ± 0.1
10 1.2 ± 0.1 18.5 ± 0.6 4.1 ± 0.1
CXCL8 233 1 2.9 ± 0.05 38 ± 2.7 3.2 ± 0.0
10 3.2 ± 0.1 69 ± 1.1 10.2 ± 0.2
T1–18 1 2.1 ± 0.1 25 ± 4.3 2.5 ± 0.3
10 3.2 ± 0.2 74 ± 1.7 9.3 ± 0.1
CCL5 233 1 0.9 ± 0.01 6.6 ± 0.3 6.0 ± 0.1
10 1.1 ± 0.1 14.7 ± 0.6 28 ± 1.1
T1–18 1 1.0 ± 0.01 3.7 ± 1.2 4.9 ± 0.4
10 1.0 ± 0.1 13.4 ± 1.2 33 ± 2.8
NOS2A 233 1 1.0 ± 0.04 55 ± 3.2 2.0 ± 0.1
10 1.0 ± 0.02 119 ± 5.4 7.3 ± 0.1
T1–18 1 0.9 ± 0.13 31 ± 12.8 1.7 ± 0.1
10 1.0 ± 0.05 112 ± 9.7 6.1 ± 0.3
LAP 233 1 1.0 ± 0.08 2.9 ± 0.08 17 ± 3.5
10 1.0 ± 0.04 4.6 ± 0.48 47 ± 1.0
T1–18 1 0.9 ± 0.05 2.2 ± 0.22 11 ± 1.4
10 1.0 ± 0.04 4.2 ± 0.03 39 ± 0.7
SAA3 233 1 1.1 ± 0.02 34 ± 4.6 31 ± 2.2
10 1.1 ± 0.00 50 ± 0.6 124 ± 30
T1–18 1 1.1 ± 0.02 23 ± 6.9 45 ± 8.0
10 1.2 ± 0.01 50 ± 1.6 119 ± 18
CYP1A1 233 1 1.0 ± 0.02 1.7 ± 0.1 1.0 ± 0.04
10 2.1 ± 0.03 25 ± 1.5 1.5 ± 0.1
T1–18 1 1.0 ± 0.03 1.4 ± 0.2 1.3 ± 0.2
10 1.8 ± 0.11 20 ± 0.6 1.8 ± 0.1
Page 10 of 14Günther et al. Vet Res  (2016) 47:13 
Time after challenge [h]
m
R
N
A
 in
du
ct
io
n 
[fo
ld
s 
vs
. c
on
tr
ol
]
A
*
*
TNF
1
10
100
0 6 12 18 24
* *
**
*
IL6
0.1
1
10
100
1000
10000
0 6 12 18 24
E.coli 1303
S. uberis 0140J
S. uberis 233
S. uberis T1-18
S. uberis T2-58
*
**
CXCL2
1
10
100
1000
0 6 12 18 24
**
* *
*
0.1
1
10
100
1000
10000
0 6 12 18 24
CCL5
*
0
2
4
6
8
5.1 ± 0.3 5.3 ± 0.6 6.9 ± 0.3
1303 0140J 233
E. coli S. uberis
*
*
*
N
F-
B
in
du
ct
io
n
[fo
ld
s 
vs
. c
on
tr
ol
]
B
κ
Figure 5 Streptococcus uberis particles significantly activated immune gene expression and NF-κB in macrophages. A Murine 
macrophage RAW 264.7 cells were stimulated for the time as indicated (abscissa) with 30 µg/mL of heat‑killed particles of E. coli1303 or of the S. 
uberis strains 0140J, 233, T1–18, and T2–58. TNF, IL6, CXCL2, and CCL5 mRNA concentrations were measured from duplicate assays and expressed 
as multiples of the concentration from unstimulated controls (*p < 0.05). B RAW 264.7 cells were transfected with the ELAM driven reporter gene 
construct (100 ng) and stimulated with 30 µg/mL of heat‑killed particles of E. coli1303 or of the S. uberis strains 0140J or 233 for 24 h. Renilla activity 
was measured from those cell lysates and expressed as multiple of the respective unstimulated control (ordinate, tabulated values below the graph, 
mean ± SEM, n = 2 independent experiments, each assayed in triplicate, * p < 0.05).
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their species. Using heat-killed preparations of 14 differ-
ent strains we found (1) that none of these strains signifi-
cantly induced any substantial immune gene expression 
and (2) no indication of any significant quantitative differ-
ence in the responses in pbMEC induced by isolates from 
clinical or subclinical cases of mastitis. Moreover, this 
uniform escape from alerting immune functions in this 
specific cell type of the host was independent from the 
capacity of S. uberis for capsule formation (0140J forms a 
capsule while 233 does not [14]; similar reaction observed 
against 0140J and its mutant 0140JΔhas) or the virulent vs. 
avirulent phenotype of the S. uberis pathogens.
The lack of MEC responsiveness against the challenging 
pathogens was not due to gross surface alterations associ-
ated with the heat inactivation of the pathogens, since short-
term co-culture with live pathogens and their subsequent 
inactivation with gentamicin conceivably left the surface 
structure of the pathogens unchanged and nevertheless did 
not cause a much stronger reaction. Gram-positive bacteria 
are known to evade immune recognition through mask-
ing with serum components [55–57]. However, our control 
experiment challenging the MEC in serum free medium 
proved that no such mechanism was responsible for the 
general unresponsiveness in the current study. The slightly 
enforced reactivity of the MEC against the live pathogens 
might be due the presence of some small RNA molecules 
which are found on the surface of live pathogens but which 
might have been washed away during the heat inactivation 
procedure. Such “vita-PAMPs” were found to eventually 
induce stronger expression of some immune genes (exam-
ples IFN-β, IL1-β) but not of others, such as IL6 [58]. Indeed, 
small RNA molecules have also been found adhering to the 
surface of S. uberis (JA Leigh, personal communication).
Considering all these controls we can therefore exclude 
technical errors as cause for the observed immune unre-
sponsiveness of the MEC against a wide variety of S. 
uberis strains which all had been isolated from the bovine 
mammary gland. However, our data are at variance with 
a few reports that some particular strains did indeed 
induce some immune reaction in pbMEC cultures [14, 
29]. Such strains must be rare since we did not find a sin-
gle isolate with these properties in our collection of more 
than twenty different strains.
Streptococcusuberis does not activate substantial 
TLR‑signaling in MEC
We identify complete absence of any S. uberis induced 
TLR-signaling in MEC as a major molecular cause for 
the failure of these cells to mounting an immune defense 
against pathogens of this species. This was revealed since 
neither challenging the pbMEC with heat-killed nor with 
live pathogens increased the level of active NF-κB factors. 
Activation of this transcription factor complex however 
is the integrating indicator for PRR-signaling, including 
TLR- and NOD- signaling [30, 31]. We also validated in 
particular that S. uberis does not activate TLR2-signaling 
confirming previous reports [41]. Moreover, our results 
demonstrate that the failure to activate PRR signaling is 
peculiar to S. uberis from among the streptococcal spe-
cies complex. S. agalactiae and S. dysgalactiae activated 
the bovine TLR2 receptor in HEK293 cells. TLR2 activa-
tion through S. agalactiae was also previously reported 
[37], but has not been found by two other groups [40, 41]. 
No explanation can be given to resolve this discrepancy.
Purified LTA from S. uberis, but not other cell envelope 
components can in principle activate immune functions 
in MEC
We examined the immune stimulatory properties of 
LTA, glycolipids, lipids and lipoproteins isolated from 
S. uberis. Only LTA was found to significantly stimulate 
an immune response in MEC. LTA is an integral compo-
nent of the cell envelope of Gram-positive bacteria [59]. 
It is long known as having immune stimulatory proper-
ties, but it still is questionable which PRR is its cognate 
receptor. The controversial debate regarding the role of 
TLR2 for LTA recognition has recently been summa-
rized [60]. Our observation that isolated LTA from two 
different S. uberis strains strongly induced immune gene 
expression in MEC to similar extent is well in line with 
a wealth of reports showing the immune stimulatory 
function of such molecules [47, 61, 62]. Nuclear mag-
netic resonance spectroscopy experiments showed no 
structural differences between the LTAs isolated from 
strain 233 and T1-18 [43]. Detailed structural analysis of 
LTA from strain 233 revealed that this LTA may be typi-
cal for streptococcal LTA, since its structure was found 
to be very similar to LTAs prepared from S. agalactiae 
and S. dysgalactiae [46]. Significant NF-κB activation 
through the S. uberis derived LTA preparations in MEC 
strongly suggests activation of PRR-mediated signaling, 
but not involving TLR2 according to our data. Activa-
tion of NF-κB was associated with the integrity of the 
native LTA preparation. These are known to be possibly 
contaminated with co-purifying lipoproteins [60]. The 
immune stimulatory properties of LTA and lipoproteins 
can be inactivated by H2O2 oxidation [47], and this treat-
ment abolished any significant NF-κB activation in MEC 
through our LTA preparations.
Clearly, our data do not allow identification of the LTA 
receptor. Obviously, TLR2 is not involved in mediating 
the LTA elicited response. This is in line with previous 
reports that chemically synthesized LTA does not acti-
vate TLR2 signaling [63]. Nevertheless, our data show 
that isolated cell envelope components of S. uberis may 
indeed strongly activate immune functions in MEC. This 
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suggests, in turn that such immune stimulatory compo-
nents are structurally arranged in the cell envelope such 
that they are unrecognizable to the relevant PRRs of the 
MEC. Hence, the design of the outer surface of the S. 
uberis cell apparently provides a “magic hood” preventing 
recognition of the pathogen by the MEC.
S. uberis activates immune response in macrophages
We were curious to learn if the sluggish immune response 
towards S. uberis was peculiar to the MEC phenotype and 
therefore stimulated the murine macrophage model cell 
RAW264.7 with the very same S. uberis preparations as used 
before. We validated in a separate study (Günther J, Koy, 
M, Schuberth, HJ, Seyfert HM; unpublished, manuscript 
in preparation) that the pathogen-species specific immune 
response of the RAW264.7 is very similar as recorded from 
primary bovine monocyte derived macrophages (MDM). 
There is some evidence that S. uberis may be phagocytosed 
by macrophages [64, 65], but to the best of our knowledge 
quantification of the immune response of macrophages 
against S. uberis has not yet been reported. Using prepara-
tions from four different strains we found invariantly that 
they induced a strong expression of cytokine and chemokine 
encoding genes. This was very likely caused by strong PRR 
mediated signaling, since the challenges strongly activated 
the NF-κB factor complex. These data show very clearly 
that professional immune cells are capable of recognizing S. 
uberis as a threatening pathogen. One of the key functions 
of these cells is to engulf and digest pathogens. Phagocytosis 
is not a key function of epithelial cells, such as MEC. Hence, 
it was perhaps not surprising to find that eventually invaded 
S. uberis pathogens may persist as structurally intact parti-
cles inside of MEC [66]. However, intra-cellular digestion 
of Gram-positive bacteria and subsequent activation of 
intracellular PRRs, such as TLR9 or NOD2 was found in 
many cases to be pivotal for mounting an adequate immune 
response against those invaders (see review [55]). Hence, 
data from this study here highlight in turn that the failure of 
the MEC to respond to the S. uberis challenge is specifically 
related to the MEC phenotype.
In summary, we demonstrated here that all the strains 
from our large collection of S. uberis isolates from clinical 
and subclinical cases of mastitis evaded the immune surveil-
lance of the MEC, representing by far the most abundant 
first line sentinels of the udder. Failure to activating their 
immune alert early on after infection explains the com-
monly observed belated and weak onset of udder inflamma-
tion during S. uberis mastitis. We proved, on the other hand 
that macrophages can indeed mount a vigorous immune 
response against S. uberis. Hence, our data collectively imply 
that the observed large fraction of subclinical mastitis associ-
ated with S. uberis infections is determined by the pathogen-
species specific immune response of MEC. The sometimes 
occurring severe cases of clinical mastitis after S. uberis 
infection may relate to specific properties of the individual 
cow, conceivably including an altered setting and equipment 
of the udder with resident professional immune cells.
Additional files
Additional file 1:  Sequences of the oligonucleotide primers used 
for real-time PCR quantification. Primer sequences and source files for 
the respective genes are indicated.
Additional file 2: Extent and kinetics of modulated mRNA con-
centrations after stimulating pbMEC with heat-killed E. coli1303 or 
four different S. uberis strains for 6 and 24 h. Values are means of fold 
changes of the respective mRNA concentration (relative to the unstimu‑
lated control culture) from two biological replica experiments (± SEM), 
each assayed in duplicate; bold numbers represent significant regulation.
Additional file 3: Extent and kinetics of modulated mRNA concen-
trations after stimulating pbMEC in serum free medium with E. 
coli1303, S. aureus strain 1027 or S. uberis strain 233. Values are means 
from two biological replica experiments (± SEM) of fold changes relative 
to unstimulated control; bold numbers represent significant regulation 
(Anova, Bonferroni post‑tests).
Additional file 4: S. uberis pretreatment of pbMEC did not change 
the immune response against a subsequent E. coli challenge. 
pbMEC were pretreated (primed) with 30 µg/mL heat‑killed particles from 
S. uberis strain 0140J or 233 for one hour. Subsequently the cells were 
washed three times with PBS and cultivated in normal growth medium 
(0140J priming, 233 priming) or were challenged with 3 µg/mL heat‑killed 
particles from E. coli strain 1303 (0140J priming + E. coli, 233 priming 
+ E. coli) for another 1 h, 3 h or 24 h. To analyze the response against E. 
coli without priming pbMEC were cultivated one hour in normal growth 
medium, washed three times with PBS and were challenged with 3 µg/
mL E. coli particles only for 1 h, 3 h or 24 h (E. coli). Cells were harvested 
at the end of the experiment and total RNA was prepared. TNF, CXCL8, 
NOS2A, and LAP mRNA concentrations were measured with RT‑qPCR and 
expressed as multiples of the concentration from unstimulated controls. 
Data are from a single experiment, assayed in duplicate.
Additional file 5: Other membrane anchored components of the 
cell envelope from S. uberis strain 233 did not significantly activate 
NF-κB in pbMEC. pbMEC were transfected with the ELAM driven reporter 
gene construct (100 ng) and stimulated with 10 µg/mL of the indicated 
S. uberis component or 30 µg/mL E. coli1303 for 24 h. The luciferase activity 
was measured from cell lysates and normalized against their protein 
concentration. Values are expressed as fold increase above the level of the 
unstimulated control (ordinate). Each transfection was run in duplicate 
and assayed from triplicate challenges. (*p < 0.05). Components of the 
S. uberis cell envelope were prepared by bead disruption of the cells as 
described for the LTA preparation in the Material and Methods section of 
the main text. Lipoproteins were obtained by Triton X‑114 phase partition‑
ing of the membrane fraction as described [67]. Lipids were extracted 
according to the method of Bligh and Dyer [68]. Thin Layer Chromatogra‑
phy (TLC) was used to identify glycolipid in the total lipid extract. Samples 
were developed using a mixture of chloroform/methanol/H2O (65/25/4, 
v/v/v) and visualized with Hanessian’s and α‑naphtol stain. Three glycolip‑
ids G1, G2 and G3 were identified. To isolate these glycolipids the crude 
lipid extract was fractionated on activated Silica Gel 60 and glycolipids 
were successively eluted with chloroform/methanol in the ratios of 9.5:0.5 
(G1), 9:1 (G2), and 1:1 (G3). Those fractions were dried and further purified 
by preparative TLC to obtain pure specific substances. In the NF‑κB assay 
lipoproteins were used untreated (native), proteinase K (PK) or H2O2 
treated (perox). Furthermore NF‑κB activation capacity of water and inter 
phase from the lipid extraction procedure and of the three glycolipids was 
examined and compared to a challenge with E. coli. The data regarding 
the lipoproteins show that the slight NF‑κB activation is not specifically 
related to lipoproteins, since both, proteinase K as well as H2O2 treatment 
destroys the structural integrity of such molecules.
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